EQ-5D Based Utility Values for Adults with Chronic Obstructive Pulmonary Disease: A Systematic Review, Meta-Analysis, and Meta-Regression

References

• Overview | Chronic obstructive pulmonary disease in over 16s: diagnosis and management | Guidance | NICE [Internet]. NICE; 2018 [cited 2024 Apr 2]. Available from: https://www.nice.org.uk/guidance/ng115
   Google Scholar
• Wang L, Xie J, Hu Y, et al. Air pollution and risk of chronic obstructed pulmonary disease: the modifying effect of genetic susceptibility and lifestyle. EBioMedicine. 2022;79:103994. doi: 10.1016/j.ebiom.2022.103994.
   PubMed Web of Science ®Google Scholar
• Risk factors | Background information | Chronic obstructive pulmonary disease | CKS | NICE [Internet]; 2024 [cited 2024 Apr 2]. Available from: https://cks.nice.org.uk/topics/chronic-obstructive-pulmonary-disease/background-information/risk-factors/
   Google Scholar
• Steiner MC, Lowe D, Beckford K, et al. Socioeconomic deprivation and the outcome of pulmonary rehabilitation in England and Wales. Thorax. 2017;72(6):530–537. doi: 10.1136/thoraxjnl-2016-209376.
   PubMed Web of Science ®Google Scholar
• Ståhl E, Lindberg A, Jansson S-A, et al. Health-related quality of life is related to COPD disease severity. Health Qual Life Outcomes. 2005;3(1):56. doi: 10.1186/1477-7525-3-56.
   PubMedGoogle Scholar
• 7 Incorporating Economic Evaluation | Developing NICE guidelines: the manual | Guidance | NICE [Internet]. NICE; 2014 [cited 2024 Apr 2]. Available from: https://www.nice.org.uk/process/pmg20/chapter/incorporating-economic-evaluation
   Google Scholar
• Moayeri F, Hsueh YSA, Clarke P, et al. Health state utility value in chronic obstructive pulmonary disease (COPD); the challenge of heterogeneity: a systematic review and meta-analysis. COPD. 2016;13(3):380–398. doi: 10.3109/15412555.2015.1092953.
   PubMedGoogle Scholar
• Starkie HJ, Briggs AH, Chambers MG, et al. Predicting EQ-5D values using the SGRQ. Value Health. 2011;14(2):354–360. doi: 10.1016/j.jval.2010.09.011.
   PubMed Web of Science ®Google Scholar
• 1 Introduction | Developing NICE guidelines: the manual | Guidance | NICE [Internet]. NICE; 2014 [cited 2024 Apr 2]. Available from: https://www.nice.org.uk/process/pmg20/chapter/introduction
   Google Scholar
• Foreword | Guide to the methods of technology appraisal 2013 | Guidance | NICE [Internet]. NICE; 2013 [cited 2024 Apr 2]. Available from: https://www.nice.org.uk/process/pmg9/chapter/foreword
   Google Scholar
• NICE [Internet]. Position statement on use of the EQ-5D-5L value set for England (updated October 2019) | Technology appraisal guidance | NICE guidance | Our programmes | What we do | About. NICE; 2024 [cited 2024 Apr 2]. Available from: https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/technology-appraisal-guidance/eq-5d-5l
   Google Scholar
• Peasgood T, Brazier J. Is meta-analysis for utility values appropriate given the potential impact different elicitation methods have on values? Pharmacoeconomics. 2015;33(11):1101–1105. doi: 10.1007/s40273-015-0310-y.
   PubMed Web of Science ®Google Scholar
• Hao Y, Wolfram V, Cook J. A structured review of health utility measures and elicitation in advanced/metastatic breast cancer. Clinicoecon Outcomes Res. 2016;8:293–303. doi: 10.2147/CEOR.S100448.
   PubMed Web of Science ®Google Scholar
• PRISMA [Internet]. [cited 2024 Apr 2]. Available from: http://prisma-statement.org/prismastatement/checklist.aspx?AspxAutoDetectCookieSupport=1
   Google Scholar
• 9.6.4 Meta-regression [Internet]. [cited 2024 Apr 2]. Available from: https://handbook-5-1.cochrane.org/chapter_9/9_6_4_meta_regression.htm
   Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease-GOLD [Internet]. Global Initiative for Chronic Obstructive Lung Disease; 2024 [cited 2024 Apr 2]. Available from: https://goldcopd.org/
   Google Scholar
• Ahn JH, Chung JH, Shin K-C, et al. The effects of repeated inhaler device handling education in COPD patients: a prospective cohort study. Sci Rep. 2020;10(1):19676. doi: 10.1038/s41598-020-76961-y.
   PubMed Web of Science ®Google Scholar
• Alcazar-Navarrete B, Fuster A, García Sidro P, et al. Relationship between clinical control, respiratory symptoms and quality of life for patients with COPD. Int J Chron Obstruct Pulmon Dis. 2020;15:2683–2693. doi: 10.2147/COPD.S265470.
   PubMed Web of Science ®Google Scholar
• Altawalbeh SM, Almomani BA, Alefan Q, et al. The influence of adverse drug effects on health-related quality of life in chronic obstructive pulmonary disease patients. Int J Pharm Pract. 2022;30(5):457–465. doi: 10.1093/ijpp/riac052.
   PubMed Web of Science ®Google Scholar
• Bae E, Choi SE, Lee H, et al. Validity of EQ-5D utility index and minimal clinically important difference estimation among patients with chronic obstructive pulmonary disease. BMC Pulm Med. 2020;20(1):73. doi: 10.1186/s12890-020-1116-z.
   PubMed Web of Science ®Google Scholar
• Baltasar-Fernandez I, Losa-Reyna J, Carretero A, et al. Residual effects of 12 weeks of power-oriented resistance training plus high-intensity interval training on muscle dysfunction, systemic oxidative damage, and antioxidant capacity after 10 months of training cessation in older people with COPD. Scand J Med Sci Sports. 2023;33(9):1661–1676. doi: 10.1111/sms.14428.
   PubMed Web of Science ®Google Scholar
• Boland MRS, van Boven JFM, Kruis AL, et al. Investigating the association between medication adherence and health-related quality of life in COPD: methodological challenges when using a proxy measure of adherence. Respir Med. 2016;110:34–45. doi: 10.1016/j.rmed.2015.11.008.
   PubMed Web of Science ®Google Scholar
• van Boven JFM, Stuurman-Bieze AGG, Hiddink EG, et al. Effects of targeting disease and medication management interventions towards patients with COPD. Curr Med Res Opin. 2016;32(2):229–239. doi: 10.1185/03007995.2015.1110129.
   PubMed Web of Science ®Google Scholar
• Burns DK, Wilson ECF, Browne P, et al. The cost effectiveness of maintenance schedules following pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: an economic evaluation alongside a randomised controlled trial. Appl Health Econ Health Policy. 2016;14(1):105–115. doi: 10.1007/s40258-015-0199-9.
   PubMed Web of Science ®Google Scholar
• Chen YT, Ying YH, Chang K, et al. Study of patients’ willingness to pay for a cure of chronic obstructive pulmonary disease in Taiwan. Int J Environ Res Public Health. 2016;13(3):273. doi: 10.3390/ijerph13030273.
   PubMed Web of Science ®Google Scholar
• Choi JT, Seo JH, Ko MH, et al. Validation of Korean version of the London Chest Activity of Daily Living Scale in patients with chronic obstructive pulmonary disease. Ann Rehabil Med. 2018;42(2):329–335. doi: 10.5535/arm.2018.42.2.329.
   PubMedGoogle Scholar
• Ding B, Small M, Bergström G, et al. A cross-sectional survey of night-time symptoms and impact of sleep disturbance on symptoms and health status in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:589–599. doi: 10.2147/COPD.S122485.
   PubMed Web of Science ®Google Scholar
• Fishwick D, Lewis L, Darby A, et al. Determinants of health-related quality of life among residents with and without COPD in a historically industrialised area. Int Arch Occup Environ Health. 2015;88(6):799–805. doi: 10.1007/s00420-014-1008-8.
   PubMed Web of Science ®Google Scholar
• Garcia-Gordillo MÁ, Collado-Mateo D, Olivares PR, et al. A cross-sectional assessment of health-related quality of life among patients with chronic obstructive pulmonary disease. Iran J Public Health. 2017;46(8):1046–1053.
   PubMed Web of Science ®Google Scholar
• Hansen H, Beyer N, Frølich A, et al. Inter-day test-retest reproducibility of the CAT, CCQ, HADS and EQ-5D-3L in patients with severe and very severe COPD. Patient Relat Outcome Meas. 2021;12:117–128. doi: 10.2147/PROM.S306352.
   PubMed Web of Science ®Google Scholar
• Hoogendoorn M, Jowett S, Dickens AP, et al. Performance of the EQ-5D-5L plus respiratory bolt-on in the Birmingham chronic obstructive pulmonary disease cohort study. Value Health. 2021;24(11):1667–1675. doi: 10.1016/j.jval.2021.05.006.
   PubMed Web of Science ®Google Scholar
• Hoyle CK, Tabberer M, Brooks J. Mapping the COPD assessment test onto EQ-5D. Value Health. 2016;19(4):469–477. doi: 10.1016/j.jval.2016.01.005.
   PubMed Web of Science ®Google Scholar
• Husain MO, Chaudhry IB, Blakemore A, et al. Prevalence of depression and anxiety in patients with chronic obstructive pulmonary disease and their association with psychosocial outcomes: a cross-sectional study from Pakistan. SAGE Open Med. 2021;9:20503121211032813. doi: 10.1177/20503121211032813.
   Web of Science ®Google Scholar
• Jiménez-Reguera B, Maroto López E, Fitch S, et al. Development and preliminary evaluation of the effects of an mHealth web-based platform (HappyAir) on adherence to a maintenance program after pulmonary rehabilitation in patients with chronic ­obstructive pulmonary disease: randomized controlled trial. JMIR mHealth uHealth. 2020;8(7):e18465. doi: 10.2196/18465.
   PubMed Web of Science ®Google Scholar
• Kokturk N, Polatli M, Oguzulgen IK, et al. Adherence to COPD treatment in Turkey and Saudi Arabia: results of the ADCARE study. Int J Chron Obstruct Pulmon Dis. 2018;13:1377–1388. doi: 10.2147/COPD.S150411.
   PubMed Web of Science ®Google Scholar
• Koo HK, Kang HK, Song P, et al. Systemic white blood cell count as a biomarker associated with severity of chronic obstructive lung disease. Tuberc Respir Dis. 2017;80(3):304–310. Jul doi: 10.4046/trd.2017.80.3.304.
   PubMed Web of Science ®Google Scholar
• Kwon HY, Kim E. Factors contributing to quality of life in COPD patients in South Korea. Int J Chron Obstruct Pulmon Dis. 2016;11:103–109. doi: 10.2147/COPD.S90566.
   PubMed Web of Science ®Google Scholar
• Kwon YS. Moderating effect of depression on the relationship between subjective health and quality of life in patients with COPD. Ind J Publ Health Res Dev. 2018;9(11):787. doi: 10.5958/0976-5506.2018.01557.7.
   Google Scholar
• Lee SH, Kwon HY. Prevalence of osteoporosis in Korean patients with chronic obstructive pulmonary disease and their health-related quality of life according to the Korea National Health and Nutrition Examination Survey 2008–2011. J Bone Metab. 2017;24(4):241–248. doi: 10.11005/jbm.2017.24.4.241.
   PubMedGoogle Scholar
• Lee K, Lee H, Lee K, et al. Gender differences in pulmonary function, physical activity, and quality of life of patients with COPD based on data from the Korea National Health and Nutrition Examination Survey 2015 to 2019 from the perspective of pulmonary rehabilitation. Medicine. 2022;101(44):e31413. doi: 10.1097/MD.0000000000031413.
   PubMed Web of Science ®Google Scholar
• Lim J, Choi SE, Bae E, et al. Mapping analysis to estimate EQ-5D utility values using the COPD assessment test in Korea. Health Qual Life Outcomes. 2019;17(1):97. doi: 10.1186/s12955-019-1148-3.
   PubMedGoogle Scholar
• Merino M, Villoro R, Hidalgo-Vega Á, et al. Health-related quality of life of patients diagnosed with COPD in Extremadura, Spain: results from an observational study. Health Qual Life Outcomes. 2019;17(1):189. doi: 10.1186/s12955-019-1244-4.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Barrecheguren M, Román-Rodríguez M. Frequency and characteristics of different clinical phenotypes of chronic obstructive pulmonary disease. Int J Tuberc Lung Dis. 2015;19(8):992–998. doi: 10.5588/ijtld.15.0021.
   PubMed Web of Science ®Google Scholar
• Nguyen TS, Nguyen TLH, Pham TTV, et al. Impact of pharmaceutical care in the improvement of medication adherence and quality of life for COPD patients in Vietnam. Respir Med. 2019;153:31–37. doi: 10.1016/j.rmed.2019.05.006.
   PubMed Web of Science ®Google Scholar
• Nolan CM, Longworth L, Lord J, et al. The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference. Thorax. 2016;71(6):493–500. doi: 10.1136/thoraxjnl-2015-207782.
   PubMed Web of Science ®Google Scholar
• Paly VF, Naya I, Gunsoy NB, et al. Long-term cost and utility consequences of short-term clinically important deterioration in patients with chronic obstructive pulmonary disease: results from the TORCH study. Int J Chron Obstruct Pulmon Dis. 2019;14:939–951. doi: 10.2147/COPD.S188898.
   PubMed Web of Science ®Google Scholar
• Richeldi L, Schino P, Bargagli E, et al. TRITRIAL: the impact of fixed triple therapy with beclometasone/formoterol/glycopyrronium on health status and adherence in chronic obstructive pulmonary disease in an Italian context of real life. Int J Chron Obstruct Pulmon Dis. 2024;19:475–487. doi: 10.2147/COPD.S445858.
   PubMed Web of Science ®Google Scholar
• Martinez Rivera C, Costan Galicia J, Alcázar Navarrete B, et al. Factors associated with depression in COPD: a multicenter study. Lung. 2016;194(3):335–343. Jun doi: 10.1007/s00408-016-9862-7.
   PubMed Web of Science ®Google Scholar
• Roncero C, Campuzano AI, Quintano JA, et al. Cognitive status among patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2016;11:543–551. doi: 10.2147/COPD.S100850.
   PubMed Web of Science ®Google Scholar
• Sohanpal R, Pinnock H, Steed L, et al. A tailored psychological intervention for anxiety and depression management in people with chronic obstructive pulmonary disease: TANDEM RCT and process evaluation. Health Technol Assess. 2024;28(1):1–129. doi: 10.3310/PAWA7221.
   PubMed Web of Science ®Google Scholar
• Sundh J, Johansson G, Larsson K, et al. Comorbidity and health-related quality of life in patients with severe chronic obstructive pulmonary disease attending Swedish secondary care units. Int J Chron Obstruct Pulmon Dis. 2015;10:173–183. doi: 10.2147/COPD.S74645.
   PubMed Web of Science ®Google Scholar
• Talboom-Kamp EP, Verdijk NA, Kasteleyn MJ, et al. High level of integration in integrated disease management leads to higher usage in the e-vita study: self-management of chronic obstructive pulmonary disease with web-based platforms in a parallel cohort design. J Med Internet Res. 2017;19(5):e185. doi: 10.2196/jmir.7037.
   PubMed Web of Science ®Google Scholar
• Thuppal S, Markwell S, Crabtree T, et al. Comparison between the EQ-5D-3L and the SF-6D quality of life (QOL) questionnaires in patients with chronic obstructive pulmonary disease (COPD) undergoing lung volume reduction surgery (LVRS). Qual Life Res. 2019;28(7):1885–1892. doi: 10.1007/s11136-019-02123-x.
   PubMed Web of Science ®Google Scholar
• Verberkt CA, van den Beuken-van Everdingen MHJ, Dirksen CD, et al. Cost-effectiveness of sustained-release morphine for refractory breathlessness in COPD: a randomized clinical trial. Respir Med. 2021;179:106330. doi: 10.1016/j.rmed.2021.106330.
   PubMed Web of Science ®Google Scholar
• Wacker ME, Jörres RA, Karch A, et al. Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities. BMC Pulm Med. 2016;16(1):70. doi: 10.1186/s12890-016-0238-9.
   PubMed Web of Science ®Google Scholar
• Wacker ME, Jörres RA, Karch A, et al. Relative impact of COPD and comorbidities on generic health-related quality of life: a pooled analysis of the COSYCONET patient cohort and control subjects from the KORA and SHIP studies. Respir Res. 2016;17(1):81. doi: 10.1186/s12931-016-0401-0.
   PubMed Web of Science ®Google Scholar
• Wu M, Zhao Q, Chen Y, et al. Quality of life and its association with direct medical costs for COPD in urban China. Health Qual Life Outcomes. 2015;13(1):57. doi: 10.1186/s12955-015-0241-5.
   PubMed Web of Science ®Google Scholar
• Xiao T, Wu K, Chen Y, et al. Quality of life and its associated factors for mild chronic obstructive pulmonary disease patients of urban community settings. Ann Palliat Med. 2020;9(4):1420–1430. doi: 10.21037/apm-19-655.
   PubMed Web of Science ®Google Scholar
• Zanforlini BM, Ceolin C, Trevisan C, et al. Clinical trial on the effects of oral magnesium supplementation in stable-phase COPD patients. Aging Clin Exp Res. 2022;34(1):167–174. doi: 10.1007/s40520-021-01921-z.
   PubMed Web of Science ®Google Scholar
• Page MJ, Sterne JAC, Higgins JPT, et al. Investigating and dealing with publication bias and other reporting biases in meta-analyses of health research: a review. Res Synth Methods. 2021;12(2):248–259. doi: 10.1002/jrsm.1468.
   PubMed Web of Science ®Google Scholar
• Vanfleteren LEGW, Ullman A, Fabbri LM. Time for a longer and better life for patients with COPD. Eur Respir J. 2018;51(1):1702569. Available from: https://erj.ersjournals.com/content/51/1/1702569
   PubMed Web of Science ®Google Scholar
• Heyworth IT, Hazell ML, Linehan MF, et al. How do common chronic conditions affect health-related quality of life? Br J Gen Pract. 2009;59(568):e353–e358. doi: 10.3399/bjgp09X453990.
   PubMed Web of Science ®Google Scholar
• Janssen MF, Bonsel GJ, Luo N. Is EQ-5D-5L better than EQ-5D-3L? A head-to-head comparison of descriptive systems and value sets from seven countries. Pharmacoeconomics. 2018;36(6):675–697. doi: 10.1007/s40273-018-0623-8.
   PubMed Web of Science ®Google Scholar
• Chie WC, Blazeby JM, Hsiao CF, et al. Differences in health-related quality of life between European and Asian patients with hepatocellular carcinoma. Asia Pac J Clin Oncol. 2017;13(5):e304–e311.
   PubMed Web of Science ®Google Scholar
• Roudijk B, Donders ART, Stalmeier PFM, et al. Cultural values: can they explain differences in health utilities between countries? Med Decis Making. 2019;39(5):605–616. Jul doi: 10.1177/0272989X19841587.
   PubMed Web of Science ®Google Scholar